通过G418处理离体纯化小鼠胰腺上皮细胞

目的：探索一种能有效去除成纤维细胞,筛选有较强增殖能力上皮细胞的方法。方法：本研究利用成纤维细胞对G418敏感的特性,在成体小鼠胰腺细胞分离后,采用悬浮细胞直接接种到含30μg/mL G418的培养基中,或细胞贴壁生长汇合至50-70%后用30至100μg/mL之间不同浓度G418处理24h、48h或72h两种方案进行上皮细胞的纯化。结果：在直接接种法培养处理中,存活的大部分细胞为成纤维细胞,上皮细胞的生长受到抑制,无法得到纯化的胰腺上皮集落;而在细胞贴壁生长汇合至50-70%后经G418处理,成纤维细胞随着处理浓度的增加死亡率也在逐渐上升,其中50μg/mL G418处理72小时对去除成纤维细胞效果最佳。结论：G418处理能够有效去除成纤维细胞,分离纯化出一群在离体条件下具有强增殖能力、形成大上皮细胞集落的细胞。该分离纯化方法为今后进一步研究成体胰腺干/祖细胞增殖与分化调控机制等问题奠定基础。     

绵羊皮肤成纤维细胞对G418及Blasticidin S抗性的研究

抗生素常被用于对转基因动物、植物及微生物细胞进行筛选。在进行抗生素抗性筛选前,需要摸索合适的抗生素使用浓度,其原因在于:过低的筛选浓度无法抑制非转基因细胞的生长;反之,过高的筛选浓度会导致转基因细胞死亡。为了摸索绵羊皮肤成纤维细胞(sheep skin fibroblasts, SSFs)对G418及Blasticidin S的抗性,本实验以体外培养的SSFs为实验材料,采用不同浓度的上述两种抗生素处理SSFs,采用活细胞计数的方式检测SSFs对上述两种抗生素的抗性。单独使用G418或Blasticidin S导致SSFs全部死亡的最低致死浓度分别为200μg/mL及4μg/mL;当两种抗生素联合使用时,其最低致死浓度为100μg/mL G418+3μg/mL Blasticidin S或150μg/mL G418+2μg/mL Blasticidin S。该实验为采用这两种抗生素筛选转基因SSFs提供了理论基础。     

小鼠离体胰腺淀粉酶释放的温度依赖性

应用小鼠离体胰腺碎片灌流技术研究了在37、25、10和40℃下胰腺的淀粉酶释放以及乙酰胆碱(ACh)对胰淀粉酶释放的刺激效应。灌流液采用Krebs-Henseleit(KH)溶液,对照温度为37℃。实验观察到:25℃时淀粉酶的释放量减低,10℃时极明显减低,而40℃时淀粉酶释放量明显增加。在KH灌流液中加入ACh对淀粉酶释放有刺激效应。但是10℃时的刺激效应比37℃时大约降低一半,而40℃时ACh对淀粉酶的刺激效应仍保持较高水平。在离体条件下基础淀粉酶释放主要是在胰内神经节影响下神经末梢释放ACh的结果。结果表明,低温可降低胰腺泡细胞对ACh的敏感性。     

G418抗性HEK293细胞的培育

目的　培育具有G418抗性的HEK2 93细胞 ,用于建立猪内源性反转录病毒感染人HEK2 93细胞的模型。方法　通过脂质体转染的方法 ,将含有neo基因的质粒pIRESneo导入HEK2 93细胞中 ,利用G418的选择特性 ,对转染细胞进行压力筛选 ,并对其进行了PCR鉴定。结果　经 6 0 0 μg ml的G418压力筛选后 ,获得了抗性细胞克隆。抗性细胞的形态和生长速度与筛选前细胞没有差异 ,特异性核苷酸引物检测抗性细胞基因组DNA ,可以扩增出对应的核苷酸片段。结论　成功地培育了G418抗性HEK2 93细胞 ,为建立猪内源性反转录病毒感染人HEK2 93细胞的模型奠定了基础。     

一株产G418单组分工程菌的构建

【目的】定向改造庆大霉素产生菌绛红小单孢菌G1008,获得产G418单组分工程菌。【方法】以温敏型穿梭质粒p KC1139为载体,构建敲除基因genQ*重组质粒p QB303,通过接合转移,导入绛红小单孢菌G1008中,影印筛选和PCR鉴定genQ*框内缺失突变菌,利用TLC和MS分析其代谢产物组分。【结果】获得一株genQ*缺失工程菌Micromonospora purpurea GQ175,其代谢产物为G418单组分,生物效价达828 mg/L,与出发菌G1008的产抗能力相当。【结论】工程菌GQ175产G418单组分,具有很好的工业开发价值。同时,证明绛红小单孢菌G1008中,庆大霉素C-6′脱氢酶基因为genQ*,且无其他同功酶基因。     

通过整体消化法分离具有集落形成能力的胰腺上皮样细胞

目的:胰腺上皮细胞能诱导成表达胰岛素的细胞,成为细胞替代疗法治疗糖尿病的重要来源。胰腺细胞的分离多采用机械剪切后胶原酶消化,本文在以往研究基础上,探索一种能分离得到更纯净的胰腺上皮样细胞的新方法。方法:本研究采用胰腺整体消化的方法,将成体小鼠整个胰腺取下,摘除系膜及大的血管,置于胶原酶中消化20min,用PBS吹打胰腺组织,得到的细胞悬液,离心后去除上清与细胞碎片,用培养基重悬实质细胞,接种于6 cm培养皿中,培养7-10天后得到单细胞集落。结果:整体消化法不剪碎胰腺组织,从而避免多种胰腺细胞的参与,得到较为纯净的胰腺上皮细胞悬液,细胞总体数量小于部分消化法,但是单细胞比率远远高于部分消化法,得到的细胞集落更纯净,不需要去除成纤维细胞,方便筛选及进一步扩大培养。结论:整体消化法能够分离纯化出一群在离体条件下具有强增殖能力、形成大的上皮样集落的细胞。该分离方法方便、快捷,为今后进一步研究成体胰腺干细胞增殖与分化调控机制等问题奠定基础。     

G418和潮霉素B双重抗性小鼠胚胎干细胞饲养层的制备

通过脂质体转染的方法,先后将含有neo基因的质粒pWL／neo和含有潮霉素基因的质粒导入NIH3T3细胞中,利用G418和潮霉素B的药物选择特性,对转染细胞进行压力筛选,经500μg／ml的G418和300μg／ml潮霉素B压力筛选后,获得了具有G418和潮霉素B双重抗性细胞克隆。抗性NIH3T3细胞的形态和生长速度与正常NIH3T3细胞没有差异,用PCR法特异性核苷酸引物检测抗性细胞基因组DNA,可以扩增出对应的核苷酸片段。生长在双抗NIH3T3细胞饲养层上ES细胞基本保持正常ES细胞特征,成功地培育了G418和潮霉素双重抗性的NIH3T3细胞,为进行pTet-on和pTRE-H-Insulin目的基因电转染ES细胞的阳性细胞克隆筛选打下了基础。     

bFGF与BDNF对损伤后成年小鼠离体培养嗅觉上皮细胞发育的影响

在成熟神经系统中,嗅觉上皮（ＯＥ）很特殊,它能不断产生新的神经元。本文用细胞培养、组织化学和免疫细胞化学技术对成年小鼠的ＯＥ进行了研究。实验显示：双极细胞ＮＦ、ＮＳＥ、ＭＡＰ２、ＯＭＰ和ｔａｕ蛋白免疫染色为阳性,但ｋｅｒａｔｉｎ免疫染色为阴性,说明双极细胞是神经元。用不同浓度血清的培养基。离体培养成年小鼠的ＯＥ,观察碱性成纤维细胞生长因子（ｂＦＧＦ）和脑源神经营养因子（ＢＤＮＦ）对ＯＥ细胞数量和突     

小鼠成纤维f胞早中期染色体标本制备及G带核型分析

目前,由于染色休病、肿瘤及JtA Fq定位研究的精确度的提高,不仅要求识别染色体,而且需要明确其精细的带型结构。本工作介绍一种小鼠成纤维细胞经体外培养获得早中期G带染色体的方法,所得带烈与目前国际普遍采用的Nesbitt及Franke标准模式图一致,单倍休帝纹迟300条。本工作特点在于方法简便. .定,带纹清晰,且可用于慢性动物实验。     

载脂蛋白E基因敲除小鼠血管外膜成纤维细胞G蛋白信号调节因子3,5的表达变化

目的:检测载脂蛋白E基因敲除小鼠(apoE(-/-))血管外膜成纤维细胞中G蛋白信号调节因子(regulator of G protein signaling,RGS)3,5的变化,探讨其在动脉粥样硬化发病中的作用.方法:体外培养高脂喂养2周的apoE(-/-)小鼠和C57BL/6小鼠动脉外膜成纤维细胞,利用基因芯片技术分析RGS3,RGS5mRNA的变化,通过RT-PCR进一步验证.结果:基因芯片数据分析显示,apoE(-/-)小鼠成纤维细胞中RGS3表达下调,与C57BL/6小鼠比值为0.46.RGS5表达上调,与C57BL/6小鼠比值为2.25.RT-PCR结果显示apoE(-/-)小鼠成纤维细胞RGS3mRNA水平低于对照组小鼠(比值为0.78),RGS5mRNA水平高于对照组小鼠(比值为2.34),与基因芯片检测结果相比,变化方向一致.结论:apoE(-/-)小鼠血管外膜成纤维细胞中选择性RGS3降低和RGS5升高可能与外膜成纤维细胞的激活密切相关,从而参与了动脉粥样硬化的发生与发展,RGS有可能成为动脉粥样硬化药物治疗及基因治疗的新靶点.     

刺槐对3种抗生素敏感性的测定

匈牙利刺槐对卡那霉素不敏感,对G418敏感,而对潮霉素极为敏感.如以NPTII基因为刺槐基因工程的选择性标记基因,则G418是理想的抗生素抗性选择试剂;如用HPT基因,则潮霉素是合适的抗生素抗性选择试剂.     

带npt-Ⅱ基因转基因水稻快速检测技术的建立

以转溶菌酶基因水稻纯系材料中花9号(ZH9(R))及其受体品种中花9号(ZH9(CK))为材料, 以ZH9(R)中携带的npt-Ⅱ基因作为辅助筛选标记, 利用抗生素对其进行处理, 建立了一套快速检测带npt-Ⅱ基因转基因水稻的技术体系。使用不同浓度的卡那霉素(Kanamycin, Kan)和G418溶液将ZH9(R)和ZH9(CK)成株离体叶片于室内室温下置于培养皿中浸泡处理, 通过观察叶片变化, 确定G418为检测带npt-Ⅱ基因转基因水稻的最佳抗生素, 将G418(溶液)80 mg/L浓度(处理4天)作为检测该类转基因水稻成株离体叶片的临界浓度。进一步用G418对ZH9(R)和ZH9(CK)种子、幼胚和幼苗进行了不同处理。确定: (1) G418(溶液)300 mg/L浓度(处理7天)作为检测该类转基因水稻种子的临界浓度; (2) G418(1/2 MS+0.5 mg/L 6-BA+1.5%蔗糖培养基)200 mg/L浓度(处理10天)作为检测该类转基因水稻幼胚的临界浓度; (3) G418(1/2 MS+0.5 mg/L 6-BA+1.5%蔗糖培养基)150 mg/L浓度(处理12天)作为检测该类转基因水稻幼苗的临界浓度, 并且通过PCR方法证实了上述结论。将这些结论应用于ZH9(R)转育后代叶片、种子、幼胚和幼苗群体的检测, 检测效果都非常明显。这为带npt-Ⅱ基因转基因水稻建立了一套简便、直观且准确的检测方法。     

parp10基因RNA干扰有效靶点的筛选及验证

目的：合成并筛选有效抑制parp10表达的siRNA。方法：根据parp10 cDNA序列,设计并合成prap10基因潜在的RNA干扰（RNAi）片段,将合成的寡核苷酸序列构建到pEGFP-C1H1U6载体中;通过双萤光素酶试验、Western blotting筛选有效的干扰序列;进一步用G418对A549细胞进行耐受度筛选,确定最低耐受度;用G418溶液对转染RNAi重组质粒的A549细胞进行筛选,通过RT-PCR鉴定干扰效果。结果：针对617bp处所构建的RNAi载体能够抑制PARP10的表达,用浓度为400μg/mL G418的McCoy′s 5A培养基筛选转染后的细胞,获得了能够表达绿色荧光标签蛋白的A549细胞株,经RT-PCR检测发现,PARP10表达受到抑制。结论：获得了能够有效抑制PARP10表达的特异性小干扰RNA（siRNA）,为进一步研究其生物学功能提供了条件。     

Interleukin-20 targets renal cells and is associated with chronic kidney disease

Interleukin (IL)-10 is an anti-inflammatory factor that suppresses renal fibrosis and improves renal function in CKD rats. IL-20 belongs to the IL-10 family; therefore, we sought to determine whether IL-20 is involved in CKD. CKD patients at stage five expressed significantly higher IL-20 in serum than controls. Immunohistochemical staining demonstrated that more IL-20 protein was expressed in the kidney tubular-epithelial cells, mesangial cells, and immune cells of CKD rats with a 5/6 nephrectomy. The lung, liver, and heart tissue of CKD rats also overexpressed IL-20. Thus, we treated two tubular epithelial cells, TKPTS and M-1 cells, with IL-20 to study its effects on CKD. IL-20 treatment induced apoptosis in these cells via caspase-3 activation. Incubating IL-20 with rat interstitial fibroblasts, NRK-49F cells, upregulated TGF-β1production, one key inducer for renal fibrogenesis. Therefore, IL-20 injured renal epithelial cells and induced fibroblasts to produce TGF-β1 that hastened the progression of CKD.     

Promoters active in mammalian cells (pSV40) and in plants (pNOS) permit expression in yeast of the Tn5 APH(3') II gene

Abstract Four plasmids were constructed by associating Escherichia coli and yeast selection markers and replication origins to a structural gene coding for aminoglycoside phosphotransferase (APH(3')) controlled by different flanking sequences. We used the two bacterial genes of Tn5 (APH(3')II) and Tn903 (APH(3')I) as such and the chimeric pSVneo (APH(3')II) and pNOSneo (APH(3')II) constructs, functional in mammalian and plant cells, respectively. Yeast clones resistant to G418 were obtained with all plasmids except with that bearing the bacterial APH(3')II gene. The three plasmids harbouring the functional APH genes, however, conferred different levels of G418 resistance to yeast.     

Can pancreatic duct-derived progenitors be a source of islet regeneration?

The regenerative process of the pancreas is of interest because the main pathogenesis of diabetes mellitus is an inadequate number of insulin-producing β-cells. The functional mass of β-cells is decreased in type 1 diabetes, so replacing missing β-cells or triggering their regeneration may allow for improved type 1 diabetes treatment. Therefore, expansion of the β-cell mass from endogenous sources, either in vivo or in vitro, represents an area of increasing interest. The mechanism of islet regeneration remains poorly understood, but the identification of islet progenitor sources is critical for understanding β-cell regeneration. One potential source is the islet proper, via the dedifferentiation, proliferation, and redifferentiation of facultative progenitors residing within the islet. Neogenesis, or that the new pancreatic islets can derive from progenitor cells present within the ducts has been reported, but the existence and identity of the progenitor cells have been debated.In this review, we focus on pancreatic ductal cells, which are islet progenitors capable of differentiating into islet β-cells. Islet neogenesis, seen as budding of hormone-positive cells from the ductal epithelium, is considered to be one mechanism for normal islet growth after birth and in regeneration, and has suggested the presence of pancreatic stem cells. Numerous results support the neogenesis hypothesis, the evidence for the hypothesis in the adult comes primarily from morphological studies that have in common the production of damage to all or part of the pancreas, with consequent inflammation and repair. Although numerous studies support a ductal origin for new islets after birth, lineage-tracing experiments are considered the “gold standard” of proof. Lineage-tracing experiments show that pancreatic duct cells act as progenitors, giving rise to new islets after birth and after injury. The identification of differentiated pancreatic ductal cells as an in vivo progenitor for pancreatic β-cells has implications for a potentially important, expandable source of new islets for diabetic replenishment therapy.     

G418对IL—2基因包装细胞的筛选

本文用高浓度的G418(800μg/ml)和低浓度的G418(200μg/ml)对包装细胞PLXSN/IL-2/PA317细胞进行40天的选择筛选培养,使其细胞呈稳定状态生长时,收集上清液转染NIH/3T3细胞,进行病毒滴度测定。试图在高选择标记的情况下筛选出高表达目的基因的包装细胞。实验结果表明:高、低浓度的G418对PLXSN/IL-2/PA317包装细胞的选择作用相同,即包装细胞的病毒滴度同选择标记物浓度无关。提示可用低浓度的G418来维持包装细胞的生命。     

Expression of recombinant human granulocyte colony-stimulating factor in CHO dhfr cells: new insights into the in vitro amplification expression system

The in vitro amplification method for heterologous gene expression in mammalian cells is based on the stable transfection of cells with long, linear DNA molecules having several copies of complete expression units, coding for the gene of interest, linked to one terminal unit, coding for the selectable marker. DNA concatenamers containing additional expression units can also be prepared: we exploited this feature by co-polymerizing expression units coding for granulocyte colony-stimulating factor (G-CSF) with cassettes for dihydrofolate reductase (DHFR) and for neomycin (Nm) resistance, as selectable markers. We were thus able to obtain high level production of G-CSF in chinese hamster ovary (CHO) dhfr^- cells by combining in vitro amplification to just one step of in vivo amplification. This approach required a considerably shorter time than the classical, stepwise amplification by methotrexate.